Latest Whitepapers

Despite the increasing adoption of lab automation in the sciences, in 2022, awareness about what it can truly do remains frustratingly limited, with most labs mistaking partial automation to mean a lab is fully automated, and other labs with fully integrated automation systems losing out on flexibility.

Creating and bringing new drugs to the market can bring huge productivity challenges as the already complex drug development process becomes lengthier and more expensive.

Historically, limited color detection, large sample volumes and manual loading were the reality of flow cytometers. Today however, flow cytometers can detect dozens of colors/markers simultaneously, saving precious samples and speeding up processing time.

Droplet Digital PCR (ddPCR) is a refined form of digital PCR that offers a scalable and practical method for the absolute quantification of nucleic acids. 2021 marks ten years since the advent of ddPCR and in that time it has revolutionized discovery, development and quality control of biopharmaceuticals such as antibody-based biologics, vaccines, and cell and gene therapies.

Validation is an important process to ensure cleanrooms meet specific standards to be classified according to the International Standards Organization (ISO). ISO classifications ensure the integrity of the products, ranging from pharmaceuticals to semiconductors, contained in the cleanroom.

Supply chain security and transparency is a key part of the risk mitigation strategy of companies manufacturing clinical diagnostic assays. Prior to the COVID-19 crisis, complex global supply chains carefully balanced capacity with demand while cost-cutting initiatives pushed towards lower cost raw material providers located in different geographies.

Over the last decade, the number of clinical trials involving recombinant adeno-associated viral (AAV) vectors has dramatically increased, the diversity of serotypes has expanded and the demand for larger quantities of highly purified material manufactured to cGMP standards has rocketed.

Download this whitepaper to discover how a contract development manufacturing organization was able to establish an AAV production platform and much more.

The battle against COVID-19 only begins with a test to identify who is infected and who is not. To accelerate an effective response, we have to move beyond the initial diagnosis to prognosis: Who is most susceptible to developing serious, life-threatening symptoms?

Currently, various treatments are available to cancer patients, such as chemotherapy, targeted therapy and immunotherapy. Targeted therapy is a type of precision medicine that targets the proteins that control the growth, division and spread of cancer cells.